Contract awardedVaccines and immunisation products

AstraZeneca supplies UKHSA's live attenuated flu vaccine for 2026/2027

  • UK Health Security Agency
  • Negotiated procedure without prior publication (above threshold), 1 bid
  • 1 August 2026 to 31 July 2028

The UK Health Security Agency (UKHSA) is buying live attenuated influenza vaccine for the 2026/2027 season from AstraZeneca.

UKHSA awarded the contract directly, without a competition. It found that only one supplier could provide the vaccine to the specification and standard it needed, so the market offered no competition.

The £225.4m contract was awarded in June 2026 and is due to end in July 2028. UKHSA can extend it twice, by 12 months each time.

Alert me to similar tenders

Contract ends July 2028

What
Vaccines and immunisation products
Supplier
AstraZeneca
Value
£225.4m
How it was bought
Negotiated procedure without prior publication (above threshold)
1 bid
Dates and next
Aug 2026 to Jul 2028
Being re-tendered now
Open

Being re-tendered now

Contract Notice · £1.0bn · closes 24 Sep 2028

See the live tender

How it was bought

2 official notices
  1. 19 Jun 2026Award noticeFind a Tender
  2. 19 Jun 2026Award noticeContracts Finder
  3. 1 Jul 2026Bids closed1 bid
  4. 1 Aug 2026Contract starts
  5. 31 Jul 2028Contract ends
  6. 24 Sep 2028Re-tender openBids dueLive tender

UK Health Security Agency has bought this 12 or more times since 2021

Typical length
2 years
Suppliers used
7
in 12 of its purchases
AwardedContractWon byValue
Sep 2026Locked3 yearsLocked·
Jun 2026Locked1 yearLocked·
Jun 2026LockedLocked·
Jun 2026Locked9 monthsLocked·
Jun 2026This purchase2 yearsAstraZeneca£225.4m

and at least 7 more

Suppliers UK Health Security Agency has used in 12 of its purchases

SupplierContractsValue
Locked3·
Locked2·
Locked2·
Locked2·
AstraZeneca Won this one1£225.4m

and 2 more

See the contracts and who won them

Figures to 21 November 2026

How it compares

With every vaccines and immunisation products award since 2021

Half of awards fall between £1.1m and £11mMedian £5.1m

Awards
125
Firms that won them
18
Median award
£5.1m
of 44 with a value
This award
Bigger than 98%
of them
Typical length
2 years

AstraZeneca ranks 7th of 18 firms for vaccines and immunisation products awards since 2021.

RankFirmAwardsValue
1Locked40£181.6m
2Locked19£271.8m
3Locked18·
4Locked15£1.71m
5Locked13£348,613
6Locked8£20,000
7AstraZeneca Won this one5£225.4m
See who wins this work

Vaccines and immunisation products at other buyers

UK Health Security Agency has awarded 2,546 contracts since 2021.

See UK Health Security Agency's page
  • AstraZeneca has won 12 public contracts since 2021, 2 of them from UK Health Security Agency.

    • Jun 2026This purchase£225.4m
    • Jul 2022Locked
    See the contracts